Results 21 to 30 of about 3,238 (182)

Stereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic Prostate Cancer: A Multicenter Retrospective Experience

Medicina, 2023
Background: The favorable role of SBRT for lymph-nodal oligometastases from prostate cancer has been reported by several retrospective and prospective experiences, suggesting a more indolent natural history of disease when compared to patients with bone ...
Francesco Cuccia, Maria Tamburo, Antonio Piras, Gianluca Mortellaro, Arianna Iudica, Antonino Daidone, Manuela Federico, Valentina Zagardo, Gianluca Ferini, Francesco Marletta, Corrado Spatola, Ivan Fazio, Sergio Filosto, Stefano Pergolizzi, Giuseppe Ferrera   +14 more
doaj   +1 more source

Stereotactic radiotherapy for brain oligometastases

Reports of Practical Oncology and Radiotherapy, 2022
Brain metastases, the most common metastases in adults, will develop in up to 40% of cancer patients, accounting for more than one-half of all intracranial tumors. They are most associated with breast and lung cancer, melanoma and, less frequently, colorectal and kidney carcinoma. Magnetic resonance imaging (MRI) is the gold standard for diagnosis. For
Lupattelli M., Tini P., Nardone V., Aristei C., Borghesi S., Maranzano E., Anselmo P., Ingrosso G., Deantonio L., di Monale e Bastia M. B.   +9 more
openaire   +7 more sources

Stereotactic radiotherapy for adrenal oligometastases

Reports of Practical Oncology and Radiotherapy, 2022
Approximately 50% of melanomas, 30-40% of lung and breast cancers and 10-20% of renal and gastrointestinal tumors metastasize to the adrenal gland. Metastatic adrenal involvement is diagnosed by computed tomography (CT ) with contrast medium, ultrasound (which does not explore the left adrenal gland well), magnetic resonance imaging (MRI) with contrast
Borghesi S., Casamassima F., Aristei C., Grandinetti A., Di Franco R.   +4 more
openaire   +4 more sources

Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature

Pulmonary Medicine, 2012
Oligometastases and oligo-recurrence are among the most important notions of metastatic and recurrent cancer. The concept of oligometastases is related to the notion that cancer patients with 1–5 metastatic or recurrent lesions that could be treated by ...
Yuzuru Niibe, Joe Y. Chang
doaj   +1 more source

Stereotactic Body Radiotherapy for Metachronous Multisite Oligo-Recurrence: A Long-Surviving Case with Sequential Oligo-Recurrence in Four Different Organs Treated Using Locally Radical Radiotherapy and a Review of the Literature

Pulmonary Medicine, 2012
Stereotactic body radiotherapy (SBRT) for oligometastases represents a recent trend in radiation oncology. While abundant data are available regarding the use of SBRT for the treatment of lung or liver oligometastases from various retrospective series ...
Hiroshi Onishi, Masatoki Ozaki, Kengo Kuriyama, Takafumi Komiyama, Kan Marino, Masayuki Araya, Ryo Saito, Shinichi Aoki, Yoshiyasu Maehata, Licht Tominaga, Mitsuhiko Oguri, Iori Watanabe, Kojiro Onohara, Meguru Watanabe, Naoki Sano, Tsutomu Araki   +15 more
doaj   +1 more source

Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy

Frontiers in Oncology, 2021
ObjectiveThis study aims to analyze the 100 most cited papers and research trends on stereotactic body radiotherapy (SBRT).MethodsWe used Web of Science to identify the 100 most frequently cited papers on SBRT on September 29, 2021 and extracted the ...
Yanhao Liu, Jinying Li, Xu Cheng, Xiaotao Zhang   +3 more
doaj   +1 more source

Stereotactic radiotherapy for liver oligometastases

Reports of Practical Oncology and Radiotherapy, 2022
The liver is the first metastatic site in 15-25% of colorectal cancer patients and one of the first metastatic sites for lung and breast cancer patients. A computed tomography (CT ) scan with contrast medium is a standard procedure for assessing liver lesions but magnetic resonance imaging (MRI) characterizes small lesions better thanks to its high ...
Menichelli C., Casamassima F., Aristei C., Ingrosso G., Borghesi S., Arcidiacono F., Lancellotta V., Franzese C., Arcangeli S.   +8 more
openaire   +2 more sources

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.

PLoS ONE, 2019
PurposeOligometastasis is a state in which cancer patients have a limited number of metastatic tumors; patients with oligometastases survive longer than those with polymetastases.
Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara, Shinya Harada, Noriko Nishinarita, Yasuhiro Hiyoshi, Mikiko Ishihara, Masashi Kasajima, Satoshi Igawa, Masanori Yokoba, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki   +14 more
doaj   +1 more source

Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options

Current Oncology, 2021
Introduction: Recent modifications in the epidemiology of oropharyngeal squamous cell carcinoma (OSCC) have led to the increase of Human papillomavirus (HPV) related metastatic head and neck cancer patients with high life expectancy even at advanced ...
Anouchka Modesto, Aurore Siegfried, Amelie Lusque, Sébastien Vergez, Jerome Sarini, Laurent Brouchet, Emmanuelle Uro-Coste, Pierre Graff-Cailleaud, Jean Pierre Delord   +8 more
doaj   +1 more source

Effective Systemic Treatment of Choroidal Metastases NSCLC With Surgery After Crizotinib: A Case Report

Frontiers in Oncology, 2022
Choroidal metastasis as an initial presenting feature of lung cancer with EML4-ALK translocation is exceedingly rare and greatly impacts patient quality of life (QOL).
Shilan Liu, Shilan Liu, Xiao Liu, Ting Wang, Chunhua Zeng, Baichen Ren, Xiaodan Yu, Min Xu, Wenjuan Li, Zhihui Qiao, Chuanyun You, Qinghui Yang, Mei Chen   +12 more
doaj   +1 more source